Nicolas Champtiaux
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 22, 2026
Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort study.
Journal: The Lancet regional health. Europe
Published: July 10, 2024
Cytomegalovirus-induced oral ulcers: A case report and literature review.
Journal: Clinical case reports
Published: December 27, 2022
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis.
Journal: Cancer discovery
Published: October 18, 2022
JAK inhibitors for the treatment of adult dermatomyositis: A pilot study.
Journal: Journal of the American Academy of Dermatology
Published: December 30, 2021
Rituximab and Cyclophosphamide in Antisynthetase Syndrome-related Interstitial Lung Disease: An Observational Retrospective Study.
Journal: The Journal of rheumatology
Published: January 30, 2020
Relationship between change in physical activity and in clinical status in patients with idiopathic inflammatory myopathy: A prospective cohort study.
Journal: Seminars in arthritis and rheumatism
Published: December 15, 2019
Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI.
Journal: Seminars in arthritis and rheumatism
Published: October 16, 2019
Anti-RNP antibodies delineate a subgroup of myositis: A systematic retrospective study on 46 patients.
Journal: Autoimmunity reviews
Published: October 01, 2019
Spondyloarthritis-Associated IgA Nephropathy.
Journal: Kidney international reports
Published: September 28, 2019
Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.
Journal: Neurology
Published: February 14, 2019
Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy.
Journal: Journal of the American Academy of Dermatology
Published: November 08, 2018
Last Updated: 09/26/2026